| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Tomography, X-Ray Computed | 52 | 2019 | 7783 | 2.150 |
Why?
|
| Head and Neck Neoplasms | 32 | 2020 | 4147 | 1.670 |
Why?
|
| Cranial Nerve Neoplasms | 7 | 2019 | 47 | 1.540 |
Why?
|
| Osteoradionecrosis | 5 | 2019 | 128 | 1.540 |
Why?
|
| Carcinoma, Squamous Cell | 34 | 2019 | 5593 | 1.330 |
Why?
|
| Magnetic Resonance Imaging | 49 | 2020 | 7895 | 1.280 |
Why?
|
| Temporal Bone | 6 | 2019 | 109 | 1.050 |
Why?
|
| Palate | 3 | 2011 | 24 | 0.730 |
Why?
|
| Positron-Emission Tomography | 8 | 2014 | 2197 | 0.590 |
Why?
|
| Laryngeal Neoplasms | 7 | 2018 | 529 | 0.580 |
Why?
|
| Mandibular Diseases | 2 | 2012 | 50 | 0.580 |
Why?
|
| Neurilemmoma | 2 | 2011 | 134 | 0.510 |
Why?
|
| Image Enhancement | 3 | 2008 | 553 | 0.470 |
Why?
|
| Neck | 5 | 2011 | 395 | 0.460 |
Why?
|
| Neoplasms, Radiation-Induced | 2 | 2011 | 402 | 0.460 |
Why?
|
| Adipose Tissue | 3 | 2008 | 715 | 0.450 |
Why?
|
| Contrast Media | 10 | 2020 | 1499 | 0.450 |
Why?
|
| Neoplasm Invasiveness | 14 | 2019 | 4048 | 0.450 |
Why?
|
| Middle Aged | 78 | 2019 | 90352 | 0.440 |
Why?
|
| Male | 91 | 2019 | 128315 | 0.440 |
Why?
|
| Oculomotor Nerve Diseases | 1 | 2013 | 22 | 0.440 |
Why?
|
| Ophthalmic Nerve | 1 | 2013 | 9 | 0.440 |
Why?
|
| Oropharyngeal Neoplasms | 5 | 2014 | 1161 | 0.430 |
Why?
|
| Meningeal Neoplasms | 5 | 2015 | 473 | 0.430 |
Why?
|
| Bone Diseases, Infectious | 1 | 2012 | 11 | 0.430 |
Why?
|
| Aged | 62 | 2019 | 73333 | 0.420 |
Why?
|
| Adult | 74 | 2019 | 82040 | 0.410 |
Why?
|
| Pleural Neoplasms | 1 | 2017 | 485 | 0.410 |
Why?
|
| Human papillomavirus 16 | 2 | 2013 | 255 | 0.400 |
Why?
|
| Soft Tissue Infections | 1 | 2012 | 93 | 0.390 |
Why?
|
| Palatal Neoplasms | 3 | 2011 | 26 | 0.390 |
Why?
|
| Humans | 126 | 2021 | 270740 | 0.390 |
Why?
|
| Superior Cervical Ganglion | 1 | 2011 | 18 | 0.390 |
Why?
|
| Palatal Obturators | 1 | 2011 | 17 | 0.380 |
Why?
|
| Dextroamphetamine | 1 | 2011 | 8 | 0.380 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2009 | 1690 | 0.370 |
Why?
|
| Maxilla | 1 | 2011 | 89 | 0.370 |
Why?
|
| Public Opinion | 1 | 2011 | 77 | 0.370 |
Why?
|
| Nose Neoplasms | 1 | 2013 | 242 | 0.360 |
Why?
|
| Professional-Patient Relations | 1 | 2011 | 114 | 0.360 |
Why?
|
| Hyoid Bone | 1 | 2009 | 8 | 0.350 |
Why?
|
| Carotid Arteries | 1 | 2011 | 250 | 0.350 |
Why?
|
| Otorhinolaryngologic Neoplasms | 1 | 2009 | 22 | 0.350 |
Why?
|
| Female | 81 | 2019 | 148940 | 0.340 |
Why?
|
| Orbital Neoplasms | 4 | 2014 | 234 | 0.340 |
Why?
|
| Vocal Cord Paralysis | 2 | 2012 | 95 | 0.340 |
Why?
|
| Artifacts | 3 | 2005 | 536 | 0.340 |
Why?
|
| Outsourced Services | 1 | 2009 | 2 | 0.330 |
Why?
|
| Unnecessary Procedures | 1 | 2010 | 101 | 0.330 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 2 | 2014 | 240 | 0.330 |
Why?
|
| Thyroglossal Cyst | 1 | 2009 | 14 | 0.330 |
Why?
|
| Teleradiology | 1 | 2009 | 13 | 0.320 |
Why?
|
| Paranasal Sinus Neoplasms | 3 | 2007 | 285 | 0.320 |
Why?
|
| Papillomavirus Infections | 2 | 2014 | 999 | 0.300 |
Why?
|
| Facial Nerve Diseases | 2 | 2019 | 21 | 0.300 |
Why?
|
| Pattern Recognition, Automated | 1 | 2008 | 120 | 0.300 |
Why?
|
| Academic Medical Centers | 1 | 2011 | 681 | 0.300 |
Why?
|
| Soft Tissue Injuries | 1 | 2008 | 48 | 0.290 |
Why?
|
| Nasal Septum | 1 | 2007 | 29 | 0.290 |
Why?
|
| Ulcer | 1 | 2008 | 79 | 0.290 |
Why?
|
| Maxillary Sinus Neoplasms | 2 | 2000 | 114 | 0.280 |
Why?
|
| Thyroidectomy | 1 | 2010 | 489 | 0.280 |
Why?
|
| Dimethylpolysiloxanes | 1 | 2006 | 22 | 0.280 |
Why?
|
| Physician's Role | 1 | 2009 | 230 | 0.280 |
Why?
|
| Carcinoma, Adenoid Cystic | 4 | 2008 | 444 | 0.270 |
Why?
|
| Skull Neoplasms | 2 | 2000 | 68 | 0.270 |
Why?
|
| Silicones | 1 | 2006 | 60 | 0.270 |
Why?
|
| Neoplasm Recurrence, Local | 17 | 2018 | 10400 | 0.270 |
Why?
|
| Abscess | 1 | 2007 | 192 | 0.260 |
Why?
|
| Polytetrafluoroethylene | 1 | 2006 | 109 | 0.260 |
Why?
|
| Lacrimal Apparatus Diseases | 1 | 2007 | 144 | 0.260 |
Why?
|
| Orbit | 5 | 2003 | 209 | 0.260 |
Why?
|
| Radiology | 1 | 2011 | 426 | 0.260 |
Why?
|
| Trigeminal Nerve Diseases | 2 | 2009 | 14 | 0.260 |
Why?
|
| Head | 2 | 2008 | 248 | 0.260 |
Why?
|
| Radiotherapy | 3 | 2009 | 1857 | 0.250 |
Why?
|
| Postoperative Complications | 4 | 2007 | 5681 | 0.250 |
Why?
|
| Laryngectomy | 4 | 2016 | 243 | 0.250 |
Why?
|
| Skull Base Neoplasms | 2 | 1999 | 339 | 0.250 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2008 | 585 | 0.240 |
Why?
|
| Sensitivity and Specificity | 8 | 2019 | 5162 | 0.230 |
Why?
|
| Cranial Nerves | 2 | 2002 | 28 | 0.230 |
Why?
|
| Orbit Evisceration | 2 | 2014 | 47 | 0.230 |
Why?
|
| Prosthesis Implantation | 1 | 2006 | 242 | 0.230 |
Why?
|
| Quality of Health Care | 1 | 2009 | 618 | 0.230 |
Why?
|
| Retrospective Studies | 24 | 2019 | 39890 | 0.230 |
Why?
|
| Thyroid Neoplasms | 3 | 2010 | 1894 | 0.230 |
Why?
|
| Surgical Flaps | 3 | 2014 | 894 | 0.230 |
Why?
|
| Diagnosis, Differential | 11 | 2015 | 4831 | 0.230 |
Why?
|
| Audiovisual Aids | 1 | 2004 | 40 | 0.220 |
Why?
|
| Aged, 80 and over | 20 | 2018 | 30998 | 0.220 |
Why?
|
| Diagnostic Imaging | 2 | 2010 | 1174 | 0.220 |
Why?
|
| Brain Diseases | 2 | 2005 | 412 | 0.220 |
Why?
|
| Radiation Injuries | 2 | 2009 | 1471 | 0.220 |
Why?
|
| Ear Neoplasms | 2 | 2017 | 64 | 0.220 |
Why?
|
| Lisdexamfetamine Dimesylate | 2 | 2014 | 2 | 0.210 |
Why?
|
| Immunocompromised Host | 1 | 2007 | 719 | 0.210 |
Why?
|
| Peripheral Nervous System Neoplasms | 2 | 2000 | 72 | 0.210 |
Why?
|
| Neck Dissection | 3 | 2012 | 294 | 0.210 |
Why?
|
| Meningioma | 2 | 2015 | 308 | 0.210 |
Why?
|
| Sacrum | 2 | 1994 | 138 | 0.210 |
Why?
|
| Facial Nerve | 2 | 1999 | 58 | 0.200 |
Why?
|
| Leprosy | 1 | 2021 | 34 | 0.190 |
Why?
|
| Ethmoid Sinus | 1 | 2001 | 27 | 0.190 |
Why?
|
| Spinal Cord Neoplasms | 3 | 2004 | 155 | 0.190 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 15 | 2018 | 16689 | 0.190 |
Why?
|
| Mucormycosis | 2 | 2000 | 118 | 0.190 |
Why?
|
| Lymphoma, Non-Hodgkin | 2 | 2010 | 1067 | 0.190 |
Why?
|
| Pterygoid Muscles | 1 | 2000 | 4 | 0.180 |
Why?
|
| Leukemic Infiltration | 1 | 2001 | 73 | 0.180 |
Why?
|
| Sarcoma | 1 | 2011 | 1839 | 0.180 |
Why?
|
| Ethmoid Bone | 1 | 2000 | 13 | 0.180 |
Why?
|
| Nasal Bone | 1 | 2000 | 15 | 0.180 |
Why?
|
| Alcohol Drinking | 2 | 2014 | 600 | 0.180 |
Why?
|
| Pharyngeal Neoplasms | 2 | 2012 | 142 | 0.180 |
Why?
|
| Masticatory Muscles | 1 | 2000 | 6 | 0.180 |
Why?
|
| Cancer Care Facilities | 2 | 2016 | 907 | 0.170 |
Why?
|
| Ear, External | 1 | 2000 | 44 | 0.170 |
Why?
|
| Ferrosoferric Oxide | 1 | 2020 | 39 | 0.170 |
Why?
|
| Neoplasms, Nerve Tissue | 1 | 1999 | 5 | 0.170 |
Why?
|
| Neck Muscles | 1 | 1999 | 33 | 0.170 |
Why?
|
| Skull Base | 2 | 2000 | 225 | 0.170 |
Why?
|
| Ferric Compounds | 1 | 2020 | 77 | 0.170 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 1 | 2002 | 382 | 0.170 |
Why?
|
| Oral Surgical Procedures | 2 | 2011 | 33 | 0.170 |
Why?
|
| Vocal Cords | 2 | 2018 | 105 | 0.170 |
Why?
|
| Angiolymphoid Hyperplasia with Eosinophilia | 1 | 1998 | 6 | 0.160 |
Why?
|
| Erlotinib Hydrochloride | 2 | 2018 | 398 | 0.160 |
Why?
|
| Burns | 1 | 2000 | 130 | 0.160 |
Why?
|
| Multimodal Imaging | 2 | 2014 | 550 | 0.160 |
Why?
|
| Maxillary Nerve | 1 | 1998 | 6 | 0.160 |
Why?
|
| Cerebral Angiography | 3 | 1994 | 148 | 0.160 |
Why?
|
| Tonsillar Neoplasms | 1 | 2019 | 81 | 0.160 |
Why?
|
| Retinoblastoma | 1 | 2000 | 189 | 0.160 |
Why?
|
| Retinal Neoplasms | 1 | 2000 | 137 | 0.160 |
Why?
|
| Pain | 3 | 2012 | 1694 | 0.160 |
Why?
|
| Lymphatic Metastasis | 8 | 2015 | 4963 | 0.150 |
Why?
|
| Spinal Nerve Roots | 3 | 1999 | 69 | 0.150 |
Why?
|
| Technology, Radiologic | 1 | 1998 | 78 | 0.150 |
Why?
|
| Metal Nanoparticles | 1 | 2020 | 161 | 0.150 |
Why?
|
| Young Adult | 12 | 2017 | 22251 | 0.150 |
Why?
|
| Gadolinium | 2 | 1998 | 169 | 0.150 |
Why?
|
| Brain Neoplasms | 4 | 2014 | 4958 | 0.150 |
Why?
|
| Single-Blind Method | 2 | 2013 | 413 | 0.150 |
Why?
|
| Supratentorial Neoplasms | 1 | 1998 | 77 | 0.150 |
Why?
|
| Adolescent | 20 | 2014 | 32767 | 0.140 |
Why?
|
| Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2001 | 331 | 0.140 |
Why?
|
| Treatment Outcome | 16 | 2016 | 33737 | 0.140 |
Why?
|
| Osteomyelitis | 1 | 2000 | 258 | 0.140 |
Why?
|
| Mouth Neoplasms | 2 | 2013 | 734 | 0.140 |
Why?
|
| Foreign Bodies | 2 | 2002 | 160 | 0.140 |
Why?
|
| Algorithms | 1 | 2008 | 3891 | 0.140 |
Why?
|
| Subarachnoid Space | 1 | 1996 | 39 | 0.140 |
Why?
|
| Software | 1 | 2004 | 1355 | 0.140 |
Why?
|
| Radiography | 5 | 2008 | 1986 | 0.130 |
Why?
|
| Smoking | 3 | 2015 | 2555 | 0.130 |
Why?
|
| Cisplatin | 7 | 2018 | 2497 | 0.130 |
Why?
|
| Dental Enamel Hypoplasia | 1 | 1996 | 2 | 0.130 |
Why?
|
| Follow-Up Studies | 10 | 2016 | 15218 | 0.130 |
Why?
|
| Pleura | 1 | 2017 | 130 | 0.130 |
Why?
|
| Melanoma | 2 | 2013 | 5595 | 0.130 |
Why?
|
| Syndactyly | 1 | 1996 | 27 | 0.130 |
Why?
|
| Microphthalmos | 1 | 1996 | 65 | 0.130 |
Why?
|
| Laminectomy | 1 | 2015 | 50 | 0.130 |
Why?
|
| Cervical Cord | 1 | 2015 | 18 | 0.120 |
Why?
|
| Facial Neoplasms | 2 | 2009 | 77 | 0.120 |
Why?
|
| Glioma | 2 | 1998 | 1978 | 0.120 |
Why?
|
| Basilar Artery | 1 | 1994 | 28 | 0.120 |
Why?
|
| Mandibular Condyle | 1 | 1994 | 6 | 0.120 |
Why?
|
| Pharynx | 3 | 2010 | 150 | 0.120 |
Why?
|
| Bone Diseases | 2 | 2014 | 143 | 0.120 |
Why?
|
| Prognosis | 9 | 2018 | 22505 | 0.120 |
Why?
|
| Myocutaneous Flap | 1 | 2014 | 32 | 0.120 |
Why?
|
| Cerebral Infarction | 1 | 1994 | 72 | 0.120 |
Why?
|
| Fascia | 1 | 2014 | 56 | 0.120 |
Why?
|
| Cerebral Veins | 1 | 1994 | 29 | 0.120 |
Why?
|
| Syringes | 1 | 1994 | 40 | 0.120 |
Why?
|
| Sphenoid Bone | 1 | 1994 | 21 | 0.120 |
Why?
|
| Embolism, Air | 1 | 1994 | 35 | 0.120 |
Why?
|
| Skin Neoplasms | 3 | 2017 | 4895 | 0.110 |
Why?
|
| Meninges | 1 | 1994 | 50 | 0.110 |
Why?
|
| Survival Analysis | 6 | 2018 | 9292 | 0.110 |
Why?
|
| Radiographic Image Enhancement | 2 | 2013 | 410 | 0.110 |
Why?
|
| Inflammation | 2 | 2009 | 2518 | 0.110 |
Why?
|
| Wood | 1 | 1993 | 18 | 0.110 |
Why?
|
| Genes, bcl-1 | 1 | 2013 | 25 | 0.110 |
Why?
|
| Biopsy | 6 | 2021 | 3484 | 0.110 |
Why?
|
| Survival Rate | 12 | 2015 | 12541 | 0.110 |
Why?
|
| Intracranial Aneurysm | 1 | 1994 | 130 | 0.110 |
Why?
|
| Skin Transplantation | 1 | 2014 | 186 | 0.110 |
Why?
|
| Angiogenic Proteins | 1 | 2013 | 39 | 0.110 |
Why?
|
| Neck Injuries | 1 | 1993 | 37 | 0.110 |
Why?
|
| Carotid Artery Diseases | 1 | 1994 | 176 | 0.110 |
Why?
|
| Central Nervous System | 1 | 1995 | 451 | 0.110 |
Why?
|
| Osteosarcoma | 1 | 2000 | 950 | 0.110 |
Why?
|
| Executive Function | 1 | 2014 | 146 | 0.110 |
Why?
|
| Hyperbaric Oxygenation | 1 | 2012 | 42 | 0.100 |
Why?
|
| Wounds, Penetrating | 1 | 1993 | 157 | 0.100 |
Why?
|
| Central Nervous System Stimulants | 1 | 2014 | 193 | 0.100 |
Why?
|
| Quinazolines | 1 | 2017 | 956 | 0.100 |
Why?
|
| Mandibular Osteotomy | 1 | 2012 | 40 | 0.100 |
Why?
|
| Osteitis Deformans | 1 | 1992 | 31 | 0.100 |
Why?
|
| Carboxymethylcellulose Sodium | 1 | 2012 | 20 | 0.100 |
Why?
|
| Aicardi Syndrome | 1 | 2012 | 17 | 0.100 |
Why?
|
| Sympathetic Fibers, Postganglionic | 1 | 2011 | 7 | 0.100 |
Why?
|
| Dental Prosthesis Retention | 1 | 2011 | 6 | 0.100 |
Why?
|
| Craniocerebral Trauma | 1 | 1993 | 154 | 0.100 |
Why?
|
| Endodermal Sinus Tumor | 1 | 2012 | 50 | 0.100 |
Why?
|
| Laryngoplasty | 1 | 2012 | 28 | 0.100 |
Why?
|
| Sarcoidosis | 1 | 1993 | 113 | 0.100 |
Why?
|
| Lumbar Vertebrae | 1 | 1993 | 247 | 0.100 |
Why?
|
| Mandible | 1 | 2012 | 191 | 0.090 |
Why?
|
| Radiopharmaceuticals | 3 | 2011 | 1341 | 0.090 |
Why?
|
| Positron Emission Tomography Computed Tomography | 1 | 2017 | 880 | 0.090 |
Why?
|
| Fluorodeoxyglucose F18 | 3 | 2011 | 1260 | 0.090 |
Why?
|
| Hearing Loss, Sensorineural | 1 | 1992 | 154 | 0.090 |
Why?
|
| Paclitaxel | 8 | 2009 | 2101 | 0.090 |
Why?
|
| Lymph Node Excision | 2 | 2009 | 2062 | 0.090 |
Why?
|
| Neoplasm Staging | 7 | 2016 | 14012 | 0.090 |
Why?
|
| Mass Screening | 1 | 1998 | 1552 | 0.080 |
Why?
|
| Disease Progression | 3 | 2019 | 6867 | 0.080 |
Why?
|
| Health Care Reform | 1 | 2010 | 64 | 0.080 |
Why?
|
| Injections | 3 | 2012 | 286 | 0.080 |
Why?
|
| Tongue | 1 | 2009 | 86 | 0.080 |
Why?
|
| Radiotherapy, Conformal | 1 | 2014 | 898 | 0.080 |
Why?
|
| Chemoradiotherapy | 1 | 2018 | 2027 | 0.080 |
Why?
|
| Granulomatosis with Polyangiitis | 1 | 1989 | 49 | 0.080 |
Why?
|
| Sinus Thrombosis, Intracranial | 1 | 1989 | 55 | 0.080 |
Why?
|
| Anti-Infective Agents | 1 | 2012 | 466 | 0.080 |
Why?
|
| Spin Labels | 1 | 2008 | 69 | 0.080 |
Why?
|
| Ear Canal | 1 | 2008 | 31 | 0.080 |
Why?
|
| Drug Resistance, Neoplasm | 2 | 2015 | 5408 | 0.080 |
Why?
|
| Incidence | 3 | 2014 | 5824 | 0.080 |
Why?
|
| Incidental Findings | 1 | 2010 | 282 | 0.080 |
Why?
|
| Nose Diseases | 1 | 2007 | 9 | 0.080 |
Why?
|
| Gadolinium DTPA | 3 | 2000 | 173 | 0.070 |
Why?
|
| Histiocytosis, Sinus | 1 | 2008 | 86 | 0.070 |
Why?
|
| Precancerous Conditions | 1 | 2014 | 1059 | 0.070 |
Why?
|
| Hernia | 1 | 2007 | 45 | 0.070 |
Why?
|
| Carcinoma, Mucoepidermoid | 1 | 2009 | 141 | 0.070 |
Why?
|
| Ifosfamide | 6 | 2009 | 358 | 0.070 |
Why?
|
| Nasolacrimal Duct | 1 | 2007 | 45 | 0.070 |
Why?
|
| Bone Neoplasms | 2 | 2017 | 2665 | 0.070 |
Why?
|
| Lymph Nodes | 3 | 2013 | 3077 | 0.070 |
Why?
|
| Quality Indicators, Health Care | 1 | 2010 | 354 | 0.070 |
Why?
|
| Lymphoma, B-Cell, Marginal Zone | 1 | 2010 | 331 | 0.070 |
Why?
|
| Salvage Therapy | 1 | 2015 | 2123 | 0.070 |
Why?
|
| Leukemia | 1 | 1995 | 1719 | 0.070 |
Why?
|
| Child | 12 | 2014 | 30559 | 0.070 |
Why?
|
| Thiazoles | 1 | 2010 | 723 | 0.070 |
Why?
|
| Guideline Adherence | 1 | 2010 | 632 | 0.070 |
Why?
|
| Risk Factors | 5 | 2015 | 17888 | 0.070 |
Why?
|
| Reproducibility of Results | 3 | 2014 | 6177 | 0.060 |
Why?
|
| Aging | 1 | 1994 | 1534 | 0.060 |
Why?
|
| Carcinoma, Papillary | 1 | 2009 | 566 | 0.060 |
Why?
|
| Sinusitis | 2 | 1998 | 148 | 0.060 |
Why?
|
| Tomography Scanners, X-Ray Computed | 1 | 2005 | 89 | 0.060 |
Why?
|
| Skin | 2 | 2001 | 1271 | 0.060 |
Why?
|
| Health Care Costs | 1 | 2010 | 699 | 0.060 |
Why?
|
| Brain | 3 | 1999 | 4208 | 0.060 |
Why?
|
| Pentetic Acid | 2 | 1995 | 49 | 0.060 |
Why?
|
| Piperidines | 1 | 2009 | 1100 | 0.050 |
Why?
|
| Sphenoid Sinusitis | 2 | 2000 | 5 | 0.050 |
Why?
|
| Glioblastoma | 1 | 2014 | 1776 | 0.050 |
Why?
|
| Radiotherapy, Adjuvant | 4 | 2016 | 2271 | 0.050 |
Why?
|
| Philadelphia | 1 | 2002 | 36 | 0.050 |
Why?
|
| Carboplatin | 4 | 2009 | 880 | 0.050 |
Why?
|
| Neoadjuvant Therapy | 1 | 2016 | 5231 | 0.050 |
Why?
|
| Neoplasm Metastasis | 5 | 2018 | 5315 | 0.050 |
Why?
|
| Organometallic Compounds | 2 | 1995 | 209 | 0.050 |
Why?
|
| Chemotherapy, Adjuvant | 5 | 2016 | 4000 | 0.050 |
Why?
|
| Decision Making | 1 | 2010 | 1252 | 0.050 |
Why?
|
| Diplopia | 1 | 2002 | 47 | 0.050 |
Why?
|
| Antineoplastic Agents | 3 | 2017 | 14617 | 0.050 |
Why?
|
| Education | 1 | 2002 | 125 | 0.050 |
Why?
|
| Pyridines | 1 | 2009 | 1313 | 0.050 |
Why?
|
| Mycobacterium leprae | 1 | 2021 | 16 | 0.050 |
Why?
|
| Cerebrospinal Fluid | 1 | 2002 | 126 | 0.050 |
Why?
|
| Reoperation | 1 | 2006 | 1392 | 0.050 |
Why?
|
| Pilot Projects | 1 | 2008 | 2828 | 0.050 |
Why?
|
| Disease-Free Survival | 5 | 2016 | 10265 | 0.050 |
Why?
|
| Ependymoma | 1 | 2004 | 264 | 0.050 |
Why?
|
| Child, Preschool | 6 | 2014 | 17061 | 0.050 |
Why?
|
| Radiotherapy Dosage | 1 | 2009 | 4019 | 0.050 |
Why?
|
| Radiology, Interventional | 1 | 2002 | 142 | 0.050 |
Why?
|
| Prolactinoma | 1 | 2000 | 13 | 0.050 |
Why?
|
| Tolosa-Hunt Syndrome | 1 | 2000 | 7 | 0.050 |
Why?
|
| Cicatrix | 1 | 2002 | 187 | 0.050 |
Why?
|
| Patient Care Team | 1 | 2006 | 823 | 0.050 |
Why?
|
| Face | 2 | 2000 | 252 | 0.050 |
Why?
|
| Dental Restoration, Permanent | 1 | 2000 | 6 | 0.050 |
Why?
|
| Maxillary Sinus | 1 | 2000 | 21 | 0.050 |
Why?
|
| Aminoquinolines | 1 | 2000 | 52 | 0.050 |
Why?
|
| Visual Acuity | 2 | 2002 | 865 | 0.050 |
Why?
|
| Dopamine Agonists | 1 | 2000 | 88 | 0.040 |
Why?
|
| Severity of Illness Index | 1 | 2011 | 4372 | 0.040 |
Why?
|
| Ultrasonography | 2 | 2021 | 1933 | 0.040 |
Why?
|
| Sphenoid Sinus | 1 | 2000 | 23 | 0.040 |
Why?
|
| Carcinoma | 2 | 2003 | 2610 | 0.040 |
Why?
|
| Observer Variation | 1 | 2002 | 709 | 0.040 |
Why?
|
| Peripheral Nerves | 1 | 2000 | 160 | 0.040 |
Why?
|
| Myelodysplastic Syndromes | 1 | 2013 | 3156 | 0.040 |
Why?
|
| Radiculopathy | 1 | 1999 | 13 | 0.040 |
Why?
|
| Radiotherapy Planning, Computer-Assisted | 1 | 2009 | 2457 | 0.040 |
Why?
|
| Adenocarcinoma | 1 | 2017 | 7914 | 0.040 |
Why?
|
| Muscular Diseases | 1 | 2000 | 161 | 0.040 |
Why?
|
| Neurologic Examination | 2 | 1997 | 262 | 0.040 |
Why?
|
| Parotid Gland | 1 | 1998 | 116 | 0.040 |
Why?
|
| Pituitary Neoplasms | 1 | 2000 | 216 | 0.040 |
Why?
|
| Fellowships and Scholarships | 1 | 2002 | 411 | 0.040 |
Why?
|
| Double-Blind Method | 2 | 2014 | 2580 | 0.040 |
Why?
|
| Dura Mater | 2 | 1997 | 85 | 0.040 |
Why?
|
| Thalidomide | 1 | 2001 | 597 | 0.040 |
Why?
|
| Pyrimidines | 1 | 2010 | 3669 | 0.040 |
Why?
|
| Angiography | 2 | 1996 | 350 | 0.040 |
Why?
|
| Respiratory Hypersensitivity | 1 | 1998 | 56 | 0.040 |
Why?
|
| Recurrence | 1 | 2006 | 4878 | 0.040 |
Why?
|
| Trigeminal Nerve | 2 | 1996 | 17 | 0.040 |
Why?
|
| Intracranial Pressure | 1 | 1999 | 197 | 0.040 |
Why?
|
| Prospective Studies | 4 | 2020 | 13414 | 0.040 |
Why?
|
| Ear, Middle | 1 | 2017 | 52 | 0.040 |
Why?
|
| Chronic Disease | 2 | 2000 | 1824 | 0.040 |
Why?
|
| Neurocytoma | 1 | 1997 | 17 | 0.040 |
Why?
|
| Nasopharyngeal Neoplasms | 1 | 1999 | 340 | 0.040 |
Why?
|
| Combined Modality Therapy | 5 | 2010 | 9039 | 0.030 |
Why?
|
| Cerebral Ventricle Neoplasms | 1 | 1997 | 76 | 0.030 |
Why?
|
| Facial Neuralgia | 1 | 1996 | 5 | 0.030 |
Why?
|
| Meningitis, Fungal | 1 | 1996 | 8 | 0.030 |
Why?
|
| Risk Assessment | 3 | 2015 | 6764 | 0.030 |
Why?
|
| Gyrus Cinguli | 1 | 1997 | 127 | 0.030 |
Why?
|
| Multivariate Analysis | 2 | 2016 | 4328 | 0.030 |
Why?
|
| Brain Stem | 1 | 1997 | 185 | 0.030 |
Why?
|
| ROC Curve | 2 | 2010 | 1248 | 0.030 |
Why?
|
| Administration, Oral | 2 | 2015 | 1608 | 0.030 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2016 | 6256 | 0.030 |
Why?
|
| Facial Paralysis | 1 | 1996 | 57 | 0.030 |
Why?
|
| Pain, Intractable | 1 | 1997 | 180 | 0.030 |
Why?
|
| Carotid Artery, External | 1 | 1995 | 10 | 0.030 |
Why?
|
| ErbB Receptors | 2 | 2017 | 2375 | 0.030 |
Why?
|
| Lymphoma, B-Cell | 1 | 2002 | 929 | 0.030 |
Why?
|
| Spinal Diseases | 2 | 1993 | 131 | 0.030 |
Why?
|
| Vocal Cord Dysfunction | 1 | 2015 | 17 | 0.030 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2010 | 4961 | 0.030 |
Why?
|
| Genes, Dominant | 1 | 1996 | 356 | 0.030 |
Why?
|
| Cavernous Sinus | 1 | 1995 | 36 | 0.030 |
Why?
|
| Platinum | 1 | 2015 | 142 | 0.030 |
Why?
|
| Corpus Callosum | 1 | 1995 | 127 | 0.030 |
Why?
|
| Matched-Pair Analysis | 1 | 2014 | 100 | 0.030 |
Why?
|
| Foramen Magnum | 1 | 1994 | 7 | 0.030 |
Why?
|
| Glass | 1 | 1994 | 33 | 0.030 |
Why?
|
| Mycoses | 1 | 1998 | 393 | 0.030 |
Why?
|
| Cohort Studies | 2 | 2018 | 9470 | 0.030 |
Why?
|
| Astrocytoma | 1 | 1997 | 326 | 0.030 |
Why?
|
| Nerve Block | 1 | 1996 | 184 | 0.030 |
Why?
|
| Causality | 1 | 2014 | 176 | 0.030 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2001 | 1269 | 0.030 |
Why?
|
| Opportunistic Infections | 1 | 1996 | 234 | 0.030 |
Why?
|
| Remission Induction | 2 | 2012 | 3656 | 0.030 |
Why?
|
| Arteriovenous Fistula | 1 | 1995 | 101 | 0.030 |
Why?
|
| Dominance, Cerebral | 1 | 1994 | 75 | 0.030 |
Why?
|
| Cranial Sinuses | 1 | 1994 | 24 | 0.030 |
Why?
|
| Feasibility Studies | 1 | 2020 | 2353 | 0.030 |
Why?
|
| Lipomatosis, Multiple Symmetrical | 1 | 1993 | 1 | 0.030 |
Why?
|
| Jugular Veins | 1 | 1994 | 113 | 0.030 |
Why?
|
| Spinal Cord | 2 | 1999 | 718 | 0.030 |
Why?
|
| Plastics | 1 | 1994 | 97 | 0.030 |
Why?
|
| Texas | 2 | 2016 | 6449 | 0.030 |
Why?
|
| Muscle, Skeletal | 1 | 2001 | 1286 | 0.030 |
Why?
|
| Awareness | 1 | 2014 | 115 | 0.030 |
Why?
|
| Klippel-Feil Syndrome | 1 | 1993 | 11 | 0.030 |
Why?
|
| Chromosome Disorders | 1 | 1996 | 423 | 0.030 |
Why?
|
| Sex Distribution | 1 | 2014 | 497 | 0.030 |
Why?
|
| Central Nervous System Diseases | 1 | 1994 | 134 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 1998 | 5056 | 0.030 |
Why?
|
| Parotid Neoplasms | 1 | 2014 | 150 | 0.030 |
Why?
|
| Age Distribution | 1 | 2014 | 727 | 0.030 |
Why?
|
| Everolimus | 1 | 2015 | 436 | 0.030 |
Why?
|
| Adenoviridae | 1 | 1998 | 1497 | 0.030 |
Why?
|
| Genetic Vectors | 1 | 1998 | 1857 | 0.030 |
Why?
|
| Syndrome | 1 | 1996 | 1407 | 0.030 |
Why?
|
| Arteries | 1 | 1994 | 291 | 0.030 |
Why?
|
| Analysis of Variance | 1 | 2016 | 2315 | 0.030 |
Why?
|
| Statistics as Topic | 1 | 2013 | 453 | 0.020 |
Why?
|
| Pregnancy Complications, Neoplastic | 1 | 2014 | 235 | 0.020 |
Why?
|
| Cervical Vertebrae | 1 | 1993 | 219 | 0.020 |
Why?
|
| Voice Quality | 1 | 2012 | 35 | 0.020 |
Why?
|
| Reference Values | 1 | 1994 | 1133 | 0.020 |
Why?
|
| Histiocytosis, Langerhans-Cell | 1 | 1995 | 284 | 0.020 |
Why?
|
| Data Collection | 1 | 1994 | 608 | 0.020 |
Why?
|
| In Vitro Techniques | 1 | 1994 | 1697 | 0.020 |
Why?
|
| Gastroesophageal Reflux | 1 | 2015 | 368 | 0.020 |
Why?
|
| Cerebellum | 1 | 1995 | 470 | 0.020 |
Why?
|
| Isotretinoin | 2 | 2002 | 160 | 0.020 |
Why?
|
| United States | 3 | 2015 | 15861 | 0.020 |
Why?
|
| Deglutition Disorders | 1 | 2015 | 489 | 0.020 |
Why?
|
| Glottis | 1 | 2010 | 68 | 0.020 |
Why?
|
| Self Report | 1 | 2014 | 796 | 0.020 |
Why?
|
| Cheek | 1 | 2009 | 56 | 0.020 |
Why?
|
| Facial Bones | 2 | 1999 | 46 | 0.020 |
Why?
|
| Chromosome Aberrations | 1 | 1996 | 2035 | 0.020 |
Why?
|
| Otologic Surgical Procedures | 1 | 2008 | 35 | 0.020 |
Why?
|
| Necrosis | 1 | 2010 | 595 | 0.020 |
Why?
|
| Cetuximab | 1 | 2009 | 474 | 0.020 |
Why?
|
| Biopsy, Fine-Needle | 1 | 2011 | 689 | 0.020 |
Why?
|
| Comorbidity | 1 | 2014 | 2394 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2016 | 5101 | 0.020 |
Why?
|
| Paranasal Sinuses | 2 | 1999 | 64 | 0.020 |
Why?
|
| Interferon-alpha | 2 | 2002 | 959 | 0.020 |
Why?
|
| Patient Care Planning | 2 | 1999 | 303 | 0.020 |
Why?
|
| Dasatinib | 1 | 2010 | 881 | 0.020 |
Why?
|
| Taxoids | 2 | 2002 | 1015 | 0.020 |
Why?
|
| Papillomaviridae | 1 | 2009 | 636 | 0.020 |
Why?
|
| Palliative Care | 1 | 1997 | 2178 | 0.020 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 1998 | 3658 | 0.020 |
Why?
|
| Maximum Tolerated Dose | 1 | 2009 | 1322 | 0.020 |
Why?
|
| Neoplasm, Residual | 1 | 2012 | 1754 | 0.020 |
Why?
|
| Prevalence | 1 | 2013 | 3404 | 0.020 |
Why?
|
| Genome, Human | 1 | 2013 | 1888 | 0.020 |
Why?
|
| Carcinoma, Renal Cell | 1 | 1996 | 2386 | 0.010 |
Why?
|
| Eye Enucleation | 1 | 2003 | 87 | 0.010 |
Why?
|
| Infusions, Intra-Arterial | 1 | 2003 | 175 | 0.010 |
Why?
|
| Antineoplastic Agents, Phytogenic | 2 | 1998 | 894 | 0.010 |
Why?
|
| Mesna | 1 | 2002 | 67 | 0.010 |
Why?
|
| Kidney Neoplasms | 1 | 1996 | 3108 | 0.010 |
Why?
|
| Biomarkers, Tumor | 1 | 2001 | 10708 | 0.010 |
Why?
|
| Cytokines | 1 | 2010 | 2825 | 0.010 |
Why?
|
| Injections, Subcutaneous | 1 | 2002 | 342 | 0.010 |
Why?
|
| Infant | 2 | 1994 | 13999 | 0.010 |
Why?
|
| Injections, Intravenous | 1 | 2002 | 591 | 0.010 |
Why?
|
| Time Factors | 1 | 2015 | 13006 | 0.010 |
Why?
|
| Forehead | 1 | 2000 | 26 | 0.010 |
Why?
|
| Vitamin E | 1 | 2001 | 132 | 0.010 |
Why?
|
| Infusions, Intravenous | 1 | 2003 | 1437 | 0.010 |
Why?
|
| Pregnancy | 1 | 2014 | 8130 | 0.010 |
Why?
|
| Practice Guidelines as Topic | 1 | 2010 | 2400 | 0.010 |
Why?
|
| Prolactin | 1 | 2000 | 169 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2009 | 4960 | 0.010 |
Why?
|
| Oropharynx | 1 | 1999 | 80 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2013 | 5776 | 0.010 |
Why?
|
| Radiotherapy, Intensity-Modulated | 1 | 2010 | 2178 | 0.010 |
Why?
|
| Ethmoid Sinusitis | 1 | 1998 | 4 | 0.010 |
Why?
|
| Fever | 1 | 2002 | 521 | 0.010 |
Why?
|
| Frontal Sinusitis | 1 | 1998 | 5 | 0.010 |
Why?
|
| Maxillary Sinusitis | 1 | 1998 | 7 | 0.010 |
Why?
|
| Nasal Cavity | 1 | 1999 | 154 | 0.010 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2009 | 3409 | 0.010 |
Why?
|
| Blotting, Southern | 1 | 1998 | 453 | 0.010 |
Why?
|
| Injections, Intralesional | 1 | 1998 | 169 | 0.010 |
Why?
|
| Chondrosarcoma | 1 | 2000 | 213 | 0.010 |
Why?
|
| Drug Synergism | 1 | 2001 | 1356 | 0.010 |
Why?
|
| Bone Remodeling | 1 | 1998 | 100 | 0.010 |
Why?
|
| Septum Pellucidum | 1 | 1997 | 11 | 0.010 |
Why?
|
| Neutropenia | 1 | 2002 | 1006 | 0.010 |
Why?
|
| Neoplasm Seeding | 1 | 1997 | 66 | 0.010 |
Why?
|
| Endoscopy | 1 | 2000 | 496 | 0.010 |
Why?
|
| Phenytoin | 1 | 1997 | 81 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 1 | 2009 | 4481 | 0.010 |
Why?
|
| Cell Cycle | 1 | 2002 | 2137 | 0.010 |
Why?
|
| Ischemia | 1 | 1999 | 400 | 0.010 |
Why?
|
| Pons | 1 | 1996 | 54 | 0.010 |
Why?
|
| Fatigue | 1 | 2002 | 1275 | 0.010 |
Why?
|
| Temporal Lobe | 1 | 1997 | 191 | 0.010 |
Why?
|
| Gene Transfer Techniques | 1 | 1998 | 804 | 0.010 |
Why?
|
| Ultrasonography, Doppler, Color | 1 | 1995 | 108 | 0.010 |
Why?
|
| Etoposide | 1 | 1997 | 907 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 2002 | 5759 | 0.010 |
Why?
|
| Veins | 1 | 1995 | 163 | 0.010 |
Why?
|
| Anticonvulsants | 1 | 1997 | 430 | 0.010 |
Why?
|
| Neuroendocrine Tumors | 1 | 2000 | 656 | 0.010 |
Why?
|
| Antineoplastic Agents, Alkylating | 1 | 1997 | 605 | 0.010 |
Why?
|
| Spinal Osteophytosis | 1 | 1993 | 7 | 0.010 |
Why?
|
| Spinal Canal | 1 | 1993 | 15 | 0.010 |
Why?
|
| Myelography | 1 | 1993 | 21 | 0.010 |
Why?
|
| Intervertebral Disc | 1 | 1993 | 23 | 0.010 |
Why?
|
| Blood Flow Velocity | 1 | 1995 | 541 | 0.010 |
Why?
|
| Sex Factors | 1 | 1998 | 2184 | 0.010 |
Why?
|
| Neoplasms, Second Primary | 1 | 2001 | 1388 | 0.010 |
Why?
|
| DNA, Neoplasm | 1 | 1998 | 1958 | 0.010 |
Why?
|
| Arnold-Chiari Malformation | 1 | 1993 | 53 | 0.010 |
Why?
|
| Spinal Cord Diseases | 1 | 1993 | 88 | 0.010 |
Why?
|
| Cholangiocarcinoma | 1 | 1997 | 504 | 0.010 |
Why?
|
| Neoplastic Cells, Circulating | 1 | 1997 | 637 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 1998 | 3476 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 1997 | 3530 | 0.010 |
Why?
|
| Scoliosis | 1 | 1993 | 145 | 0.010 |
Why?
|
| Seizures | 1 | 1997 | 1001 | 0.010 |
Why?
|
| Lung Neoplasms | 1 | 2014 | 12033 | 0.010 |
Why?
|
| Neoplasms | 1 | 1997 | 15927 | 0.010 |
Why?
|
| Cyclophosphamide | 1 | 1997 | 3245 | 0.010 |
Why?
|
| Age Factors | 1 | 1998 | 5457 | 0.000 |
Why?
|
| Apoptosis | 1 | 2002 | 7757 | 0.000 |
Why?
|
| Immunohistochemistry | 1 | 1998 | 7655 | 0.000 |
Why?
|
| Breast Neoplasms | 1 | 1999 | 16215 | 0.000 |
Why?
|